Human functional genomics has proven powerful in discovering drug targets for common metabolic disorders. Through this approach, we investigated the involvement of the purinergic receptor P2RY1 in type 2 diabetes (T2D). P2RY1 was sequenced in 9,266 participants including 4,177 patients with T2D. In ...
No comments yet
Be the first to share your thoughts!